Sweat Efficacy Assessment Results at Study Follow-Up Visits

Efficacy Measure	30 Days	3 Months	6 Months	12 Months
HDSS reduction to score of 1 or 2, n (%) [95% CI]	28 (90.3) [74.3–98.0]	29 (93.6) [78.6–99.2]	28 (90.3) [74.3–98.0]	28 (90.3) [74.3–98.0]
≥50% reduction in sweat (gravimetric), n (%) [95% CI]	28 (90.3) [74.3–98.0]	29 (93.6) [78.6–99.2]	28 (90.3) [74.3–98.0]	28 (90.3) [74.3–98.0]
Average reduction in sweat (gravimetric), % [n = 31]	83.1	82.3	82.1	81.7
Average DLQI score [n = 31]	2.5	2.7	3.1	3.0
Reduction in DLQI score, average [95% CI]*	10.4 [8.3–12.4]	10.2 [7.9–12.4]	9.6 [7.3–12.0]	9.9 [7.5–12.2]
Reduction of DLQI by ≥5 points, n (%) [95% CI]*	26 (96.3) [81.0–99.9]	24 (88.9) [70.8–97.7]	24 (88.9) [70.8–97.7]	23 (85.2) [66.3–95.8]

^*Included only patients with a baseline DLQI of ≥5 [n = 27].

^CIconfidence interval; DLQI, Dermatologic Life Quality Index.

^95%confidence intervals are shown in square brackets.